We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Before the Second Annual Site Solutions Summit got under way, FDAnews and RxTrials surveyed participants and found that half the attendees represented free-standing research sites.